Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burton

Showing results (791-800 of 1,376) with videos related to

Pageof 138
Sort By:
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent patternDavid A Nugiel, Anup Vidwans, Anna-Marie Etzkorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virusErick Giang, Marcus Dorner, Jannick C Prentoe, et al.
The American Journal of Psychiatry|August 1, 1991
Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patientsJ J Strain, J S Lyons, J S Hammer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2004
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPScGianluca Moroncini, Nnennaya Kanu, Laura Solforosi, et al.
Journal of Molecular Biology|September 12, 2006
Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretationBéatrice Luginbühl, Zoltan Kanyo, R Mark Jones, et al.
Immunity|November 21, 2015
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine DesignRaiees Andrabi, James E Voss, Chi-Hui Liang, et al.
The Canadian Journal of Cardiology|April 1, 1997
Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) InvestigatorsK K Teo, J R Burton, J DeAlmeida, et al.
Plos Pathogens|May 14, 2009
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersAnn J Hessell, Eva G Rakasz, Pascal Poignard, et al.
Journal of Virology|August 19, 2011
A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIVBrian Moldt, Niccole Schultz, D Cameron Dunlop, et al.
Pageof 138

Showing results (791-800 of 1,376) with videos related to

Sort By:
Pageof 138
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent patternDavid A Nugiel, Anup Vidwans, Anna-Marie Etzkorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virusErick Giang, Marcus Dorner, Jannick C Prentoe, et al.
The American Journal of Psychiatry|August 1, 1991
Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patientsJ J Strain, J S Lyons, J S Hammer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Robust hepatitis C virus infection in vitroJin Zhong, Pablo Gastaminza, Guofeng Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2004
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPScGianluca Moroncini, Nnennaya Kanu, Laura Solforosi, et al.
Journal of Molecular Biology|September 12, 2006
Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretationBéatrice Luginbühl, Zoltan Kanyo, R Mark Jones, et al.
Immunity|November 21, 2015
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine DesignRaiees Andrabi, James E Voss, Chi-Hui Liang, et al.
The Canadian Journal of Cardiology|April 1, 1997
Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) InvestigatorsK K Teo, J R Burton, J DeAlmeida, et al.
Plos Pathogens|May 14, 2009
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersAnn J Hessell, Eva G Rakasz, Pascal Poignard, et al.
Journal of Virology|August 19, 2011
A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIVBrian Moldt, Niccole Schultz, D Cameron Dunlop, et al.
Pageof 138